Rishabh Sethia
Papers
2
Total Citations
115
H-Index
2
About
Rishabh Sethia is a leading otolaryngologist–head and neck surgeon whose research centers on optimizing quality of life (QOL) outcomes after minimally invasive treatment for oropharyngeal cancer. His most influential work, a prospective cohort study published in 2017 (96 citations), systematically compared QOL in patients undergoing transoral robotic surgery (TORS) alone versus TORS with adjuvant radiation or chemoradiation. This landmark paper provided critical evidence that while TORS alone preserves swallowing and speech function, adding adjuvant therapy significantly impairs long-term QOL—guiding clinicians in shared decision-making about de-escalation of treatment. Dr. Sethia also pioneered the study of QOL after TORS for carcinoma of unknown primary (CUP), demonstrating in a 2017 study (19 citations) that patients maintain favorable functional outcomes one year postoperatively. His work has helped establish patient-reported outcome measures as essential endpoints in head and neck oncology, influencing surgical protocols and survivorship care. By quantifying the trade-offs between oncologic control and functional preservation, Dr. Sethia has made a lasting impact on the field, empowering surgeons to tailor treatment intensity to individual patient priorities.
Research Focus
Key Achievements
Top Papers
- 1
- 2